Onconova Therapeutics, Inc. is a Phase 3 stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer. Using a proprietary chemistry platform, Onconova has created a pipeline of targeted anti-cancer agents designed to disrupt specific cellular pathways that are important for cancer cell proliferation. Onconova has three product candidates in clinical trials and several active pre-clinical programs.
您可以决定 Medidata 要使用的Cookie类型
Medidata使用何种cookies信息
Medidata将通过使用cookies为您提供最好的网站体验,并主要用于:根据您的访问情况改善网站性能,为您提供与您的交互相对应的内容和建议,根据您的兴趣提供相关内容,并通过链接方便您在社交媒体上分享网站内容。您的cookies偏好将被保存6个月,您可以通过点击每个网页页脚的 "管理我的cookie偏好 ",随时更改设置。要了解本网站如何使用cookies的更多信息,请访问我们的隐私权政策。Privacy & Cookies Policy